0001493152-24-037731.txt : 20240920
0001493152-24-037731.hdr.sgml : 20240920
20240920211547
ACCESSION NUMBER: 0001493152-24-037731
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240919
FILED AS OF DATE: 20240920
DATE AS OF CHANGE: 20240920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOSKI ROBERT C
CENTRAL INDEX KEY: 0001234880
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32188
FILM NUMBER: 241314481
MAIL ADDRESS:
STREET 1: 1500 W UNIVERSITY PARKWAY
CITY: SARASOTA
STATE: FL
ZIP: 34243
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAGENICS INC
CENTRAL INDEX KEY: 0001174940
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 593410522
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1990 MAIN STREET
STREET 2: SUITE 750
CITY: SARASOTA
STATE: FL
ZIP: 34236
BUSINESS PHONE: 8132867900
MAIL ADDRESS:
STREET 1: 1990 MAIN STREET
STREET 2: SUITE 750
CITY: SARASOTA
STATE: FL
ZIP: 34236
4
1
ownership.xml
X0508
4
2024-09-19
0
0001174940
ORAGENICS INC
OGEN
0001234880
KOSKI ROBERT C
1990 MAIN STREET, SUITE 750
SARASOTA
FL
34236
1
0
0
0
0
Non-Employee Director Option (Right to Buy)
0.48
2024-09-19
4
A
0
65000
0
A
2024-09-19
2034-09-19
Common Stock
65000
65000
D
Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.
/s/ Julio C. Esquivel, as Attorney-in-Fact for Robert Koski
2024-09-20